Industry: Food & Beverages
Published Date: 2026-03-24
Pages: 94 Pages
Report ld: 6271368
Request Sample
Customized Report
OPO-containing Infant Formulas Market Size(US$)

CAGR 2026-2032
5.0%
Market Size,2032
USD 1,564
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global OPO-containing Infant Formulas market size was US$ 1117 million in 2025 and is forecast to reach a readjusted size of US$ 1564 million by 2032 with a CAGR of 5.0% during the forecast period 2026-2032.
OPO-containing infant formulas are specialized formulas enriched with structured triglycerides, predominantly 1,3-dioleoyl-2-palmitoylglycerol (OPO), designed to mimic the fat structure of human breast milk. OPO enhances the bioavailability of palmitic acid in a way that promotes better fat and calcium absorption, reducing the risk of constipation and improving stool consistency in infants. Key features include a balanced lipid profile, enhanced digestibility, and a role in supporting gut health by fostering beneficial microbiota. These formulas are particularly beneficial for infants who cannot be breastfed, offering improved energy utilization, growth support, and comfort in digestion, making them suitable for addressing feeding issues and ensuring optimal nutrient uptake.
In 2025, the North America OPO-containing Infant Formulas market was US$ million, while the Europe market stood at US$ million. North America accounted for % of the global market in 2025 and Europe for %. Europe’s share is expected to reach % by 2032, corresponding to a CAGR of % over the analysis period.
Major global manufacturers of OPO-containing Infant Formulas include BiosTime, Nutriben, Ausnutria, HERDS, Milupa, Shanxi Yatai, Beingmate, Abbott, Brightdairy, Feihe, among others. In 2025, the top five players accounted for approximately % of global market revenue.
In terms of sales volume, the top three players in North America accounted for about % of the market in 2025, while the top three in Europe held nearly %.
The global OPO-containing Infant Formulas market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on sales, revenue, and forecasts across regions, by Type, and by Application for 2021-2032.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Report scope, segment-level executive summary (by Type, by Application) and market evolution across the short, mid and long term
Chapter 2: Quantitative analysis of OPO-containing Infant Formulas sales and revenue at global, regional, and country levels, highlighting market size and growth potential by region
Chapter 3: Competitive landscape of OPO-containing Infant Formulas manufacturers (sales, revenue, pricing, market share, industry rankings, and M&A / expansion plans)
Chapter 4: by Type-based segmentation analysis (sales, revenue, pricing, and growth potential) to identify blue-ocean product segments
Chapter 5: by Application-based segmentation analysis (sales, revenue, pricing, and growth potential) to uncover high-value downstream markets
Chapter 6: Regional breakdown by company, customer, by Type and by Application (sales, revenue, and pricing for each segment)
Chapter 7: Key manufacturer profiles –company overview, OPO-containing Infant Formulas product descriptions and specifications, revenue, gross margins, and recent developments
Chapter 8: Industry chain analysis – upstream raw materials, manufacturing links, and downstream application sectors
Chapter 9: Sales channels and distributor analysis – routes to market and key customer interfaces
Chapter 10: Market dynamics – trends, drivers, restraints, risks for manufacturers, and the impact of relevant industry policies
Chapter 11: Key findings, main takeaways, and overall conclusions of the report.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the OPO-containing Infant Formulas value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Market Overview
1.1 OPO-containing Infant Formulas Product Scope
1.2 OPO-containing Infant Formulas by Type
1.2.1 Global OPO-containing Infant Formulas Sales by Type (2021, 2025 & 2032)
1.2.2 Cow Milk Formula
1.2.3 Goat Milk Formula
1.3 OPO-containing Infant Formulas by Application
1.3.1 Global OPO-containing Infant Formulas Sales Comparison by Application (2021, 2025 & 2032)
1.3.2 0 - 6 Month
1.3.3 6 - 12 Month
1.3.4 12 - 36 Month
1.4 Global OPO-containing Infant Formulas Market Estimates and Forecasts (2021-2032)
1.4.1 Global OPO-containing Infant Formulas Market Size (Value) and Growth Rate (2021-2032)
1.4.2 Global OPO-containing Infant Formulas Market Size (Volume) and Growth Rate (2021-2032)
1.4.3 Global OPO-containing Infant Formulas Price Trends (2021-2032)
1.5 Assumptions and Limitations
2 Market Size and Prospects by Region
2.1 Global OPO-containing Infant Formulas Market Size by Region: 2021 VS 2025 VS 2032
2.2 Global OPO-containing Infant Formulas Historical Market Scenario by Region (2021-2026)
2.2.1 Global OPO-containing Infant Formulas Sales Market Share by Region (2021-2026)
2.2.2 Global OPO-containing Infant Formulas Revenue Market Share by Region (2021-2026)
2.3 Global OPO-containing Infant Formulas Market Estimates and Forecasts by Region (2027-2032)
2.3.1 Global OPO-containing Infant Formulas Sales Estimates and Forecasts by Region (2027-2032)
2.3.2 Global OPO-containing Infant Formulas Revenue Forecast by Region (2027-2032)
2.4 Major Regions and Emerging Market Analysis
2.4.1 North America OPO-containing Infant Formulas Market Size and Prospects (2021-2032)
2.4.2 Europe OPO-containing Infant Formulas Market Size and Prospects (2021-2032)
2.4.3 China OPO-containing Infant Formulas Market Size and Prospects (2021-2032)
2.4.4 Japan OPO-containing Infant Formulas Market Size and Prospects (2021-2032)
3 Global Market Size by Type
3.1 Global OPO-containing Infant Formulas Historical Market Review by Type (2021-2026)
3.1.1 Global OPO-containing Infant Formulas Sales by Type (2021-2026)
3.1.2 Global OPO-containing Infant Formulas Revenue by Type (2021-2026)
3.1.3 Global OPO-containing Infant Formulas Average Price by Type (2021-2026)
3.2 Global OPO-containing Infant Formulas Market Estimates and Forecasts by Type (2027-2032)
3.2.1 Global OPO-containing Infant Formulas Sales Forecast by Type (2027-2032)
3.2.2 Global OPO-containing Infant Formulas Revenue Forecast by Type (2027-2032)
3.2.3 Global OPO-containing Infant Formulas Price Forecast by Type (2027-2032)
3.3 Representative Players for Different Types of OPO-containing Infant Formulas
4 Global Market Size by Application
4.1 Global OPO-containing Infant Formulas Historical Market Review by Application (2021-2026)
4.1.1 Global OPO-containing Infant Formulas Sales by Application (2021-2026)
4.1.2 Global OPO-containing Infant Formulas Revenue by Application (2021-2026)
4.1.3 Global OPO-containing Infant Formulas Average Price by Application (2021-2026)
4.2 Global OPO-containing Infant Formulas Market Estimates and Forecasts by Application (2027-2032)
4.2.1 Global OPO-containing Infant Formulas Sales Forecast by Application (2027-2032)
4.2.2 Global OPO-containing Infant Formulas Revenue Forecast by Application (2027-2032)
4.2.3 Global OPO-containing Infant Formulas Price Forecast by Application (2027-2032)
4.3 New Sources of Growth in OPO-containing Infant Formulas Applications
5 Competition Landscape by Players
5.1 Global OPO-containing Infant Formulas Sales by Player (2021-2026)
5.2 Global Top OPO-containing Infant Formulas Players by Revenue (2021-2026)
5.3 Global OPO-containing Infant Formulas Market Share by Company Type (Tier 1, Tier 2, and Tier 3), based on OPO-containing Infant Formulas revenue as of 2025
5.4 Global OPO-containing Infant Formulas Average Price by Company (2021-2026)
5.5 Global Key Manufacturers of OPO-containing Infant Formulas, Manufacturing Sites & Headquarters
5.6 Global Key Manufacturers of OPO-containing Infant Formulas, Product Type & Application
5.7 Global Key Manufacturers of OPO-containing Infant Formulas, Date of Entry into This Industry
5.8 Manufacturers Mergers & Acquisitions, Expansion Plans
6 Regional Analysis
6.1 North America Market: Players, Segments, Downstream and Major Customers
6.1.1 North America OPO-containing Infant Formulas Sales by Company
6.1.1.1 North America OPO-containing Infant Formulas Sales by Company (2021-2026)
6.1.1.2 North America OPO-containing Infant Formulas Revenue by Company (2021-2026)
6.1.2 North America OPO-containing Infant Formulas Sales Breakdown by Type (2021-2026)
6.1.3 North America OPO-containing Infant Formulas Sales Breakdown by Application (2021-2026)
6.1.4 North America OPO-containing Infant Formulas Major Customers
6.1.5 North America Market Trends and Opportunities
6.2 Europe Market: Players, Segments, Downstream and Major Customers
6.2.1 Europe OPO-containing Infant Formulas Sales by Company
6.2.1.1 Europe OPO-containing Infant Formulas Sales by Company (2021-2026)
6.2.1.2 Europe OPO-containing Infant Formulas Revenue by Company (2021-2026)
6.2.2 Europe OPO-containing Infant Formulas Sales Breakdown by Type (2021-2026)
6.2.3 Europe OPO-containing Infant Formulas Sales Breakdown by Application (2021-2026)
6.2.4 Europe OPO-containing Infant Formulas Major Customers
6.2.5 Europe Market Trends and Opportunities
6.3 China Market: Players, Segments, Downstream and Major Customers
6.3.1 China OPO-containing Infant Formulas Sales by Company
6.3.1.1 China OPO-containing Infant Formulas Sales by Company (2021-2026)
6.3.1.2 China OPO-containing Infant Formulas Revenue by Company (2021-2026)
6.3.2 China OPO-containing Infant Formulas Sales Breakdown by Type (2021-2026)
6.3.3 China OPO-containing Infant Formulas Sales Breakdown by Application (2021-2026)
6.3.4 China OPO-containing Infant Formulas Major Customers
6.3.5 China Market Trends and Opportunities
6.4 Japan Market: Players, Segments, Downstream and Major Customers
6.4.1 Japan OPO-containing Infant Formulas Sales by Company
6.4.1.1 Japan OPO-containing Infant Formulas Sales by Company (2021-2026)
6.4.1.2 Japan OPO-containing Infant Formulas Revenue by Company (2021-2026)
6.4.2 Japan OPO-containing Infant Formulas Sales Breakdown by Type (2021-2026)
6.4.3 Japan OPO-containing Infant Formulas Sales Breakdown by Application (2021-2026)
6.4.4 Japan OPO-containing Infant Formulas Major Customers
6.4.5 Japan Market Trends and Opportunities
7 Company Profiles and Key Figures
7.1 BiosTime
7.1.1 BiosTime Company Information
7.1.2 BiosTime Business Overview
7.1.3 BiosTime OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
7.1.4 BiosTime OPO-containing Infant Formulas Products Offered
7.1.5 BiosTime Recent Development
7.2 Nutriben
7.2.1 Nutriben Company Information
7.2.2 Nutriben Business Overview
7.2.3 Nutriben OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
7.2.4 Nutriben OPO-containing Infant Formulas Products Offered
7.2.5 Nutriben Recent Development
7.3 Ausnutria
7.3.1 Ausnutria Company Information
7.3.2 Ausnutria Business Overview
7.3.3 Ausnutria OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
7.3.4 Ausnutria OPO-containing Infant Formulas Products Offered
7.3.5 Ausnutria Recent Development
7.4 HERDS
7.4.1 HERDS Company Information
7.4.2 HERDS Business Overview
7.4.3 HERDS OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
7.4.4 HERDS OPO-containing Infant Formulas Products Offered
7.4.5 HERDS Recent Development
7.5 Milupa
7.5.1 Milupa Company Information
7.5.2 Milupa Business Overview
7.5.3 Milupa OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
7.5.4 Milupa OPO-containing Infant Formulas Products Offered
7.5.5 Milupa Recent Development
7.6 Shanxi Yatai
7.6.1 Shanxi Yatai Company Information
7.6.2 Shanxi Yatai Business Overview
7.6.3 Shanxi Yatai OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
7.6.4 Shanxi Yatai OPO-containing Infant Formulas Products Offered
7.6.5 Shanxi Yatai Recent Development
7.7 Beingmate
7.7.1 Beingmate Company Information
7.7.2 Beingmate Business Overview
7.7.3 Beingmate OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
7.7.4 Beingmate OPO-containing Infant Formulas Products Offered
7.7.5 Beingmate Recent Development
7.8 Abbott
7.8.1 Abbott Company Information
7.8.2 Abbott Business Overview
7.8.3 Abbott OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
7.8.4 Abbott OPO-containing Infant Formulas Products Offered
7.8.5 Abbott Recent Development
7.9 Brightdairy
7.9.1 Brightdairy Company Information
7.9.2 Brightdairy Business Overview
7.9.3 Brightdairy OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
7.9.4 Brightdairy OPO-containing Infant Formulas Products Offered
7.9.5 Brightdairy Recent Development
7.10 Feihe
7.10.1 Feihe Company Information
7.10.2 Feihe Business Overview
7.10.3 Feihe OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
7.10.4 Feihe OPO-containing Infant Formulas Products Offered
7.10.5 Feihe Recent Development
7.11 Wyeth Nutrition
7.11.1 Wyeth Nutrition Company Information
7.11.2 Wyeth Nutrition Business Overview
7.11.3 Wyeth Nutrition OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
7.11.4 Wyeth Nutrition OPO-containing Infant Formulas Products Offered
7.11.5 Wyeth Nutrition Recent Development
7.12 Deloraine
7.12.1 Deloraine Company Information
7.12.2 Deloraine Business Overview
7.12.3 Deloraine OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
7.12.4 Deloraine OPO-containing Infant Formulas Products Offered
7.12.5 Deloraine Recent Development
7.13 Yili
7.13.1 Yili Company Information
7.13.2 Yili Business Overview
7.13.3 Yili OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
7.13.4 Yili OPO-containing Infant Formulas Products Offered
7.13.5 Yili Recent Development
7.14 Kabrita
7.14.1 Kabrita Company Information
7.14.2 Kabrita Business Overview
7.14.3 Kabrita OPO-containing Infant Formulas Sales, Revenue and Gross Margin (2021-2026)
7.14.4 Kabrita OPO-containing Infant Formulas Products Offered
7.14.5 Kabrita Recent Development
8 OPO-containing Infant Formulas Manufacturing Cost Analysis
8.1 OPO-containing Infant Formulas Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Key Suppliers of Raw Materials
8.2 Manufacturing Cost Structure
8.3 Manufacturing Process Analysis of OPO-containing Infant Formulas
8.4 OPO-containing Infant Formulas Industrial Chain Analysis
9 Marketing Channels, Distributors and Customers
9.1 Marketing Channels
9.2 OPO-containing Infant Formulas Distributors List
9.3 OPO-containing Infant Formulas Customers
10 OPO-containing Infant Formulas Market Dynamics
10.1 OPO-containing Infant Formulas Industry Trends
10.2 OPO-containing Infant Formulas Market Drivers
10.3 OPO-containing Infant Formulas Market Challenges
10.4 OPO-containing Infant Formulas Market Restraints
11 Research Findings and Conclusion
12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Author Details
12.3 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global OPO-containing Infant Formulas market is projected to grow from US$ 1117 million in 2025 to US$ 1564 million by 2032, at a CAGR of 5.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-24
Pages: 157
USD 4900.00
(Single User License)
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1117 million in 2025 and is projected to reach US$ 1564 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 123
USD 3950.00
(Single User License)
The global OPO-containing Infant Formulas market was valued at US$ 1117 million in 2025 and is anticipated to reach US$ 1564 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published Date: 2026-01-08
Pages: 125
USD 2900.00
(Single User License)
The global OPO-containing Infant Formulas market is projected to grow from US$ 1069 million in 2024 to US$ 1497 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-07-31
Pages: 158
USD 4900.00
(Single User License)
The global OPO-containing Infant Formulas market size was US$ 1069 million in 2024 and is forecast to a readjusted size of US$ 1497 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 96
USD 4250.00
(Single User License)
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1069 million in 2024 and is forecast to a readjusted size of US$ 1497 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published Date: 2025-03-13
Pages: 118
USD 3950.00
(Single User License)
The global market for OPO-containing Infant Formulas was valued at US$ 1069 million in the year 2024 and is projected to reach a revised size of US$ 1497 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published Date: 2025-03-13
Pages: 93
USD 2900.00
(Single User License)
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1020 million in 2023 and is forecast to a readjusted size of US$ 1433 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030.
Published Date: 2025-01-01
Pages: 112
USD 3950.00
(Single User License)
Valued at US$ 1069 million in 2024, the global OPO-containing Infant Formulas market is forecast to reach US$ 1433 million by 2030, at a CAGR of 5.0% during the forecast period.
Published Date: 2025-01-01
Pages: 165
USD 4900.00
(Single User License)
The global market for OPO-containing Infant Formulas was valued at US$ 1020 million in the year 2023 and is projected to reach a revised size of US$ 1433 million by 2030, growing at a CAGR of 5.0% during the forecast period.
Published Date: 2025-01-01
Pages: 89
USD 2900.00
(Single User License)
The global OPO-containing Infant Formulas market is projected to grow from US$ 1117 million in 2025 to US$ 1564 million by 2032, at a CAGR of 5.0% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-24
Pages: 157
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1117 million in 2025 and is projected to reach US$ 1564 million, growing at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-01-19
Pages: 123
The global OPO-containing Infant Formulas market was valued at US$ 1117 million in 2025 and is anticipated to reach US$ 1564 million by 2032, at a CAGR of 5.0% from 2026 to 2032.
Published: 2026-01-08
Pages: 125
The global OPO-containing Infant Formulas market is projected to grow from US$ 1069 million in 2024 to US$ 1497 million by 2031, at a CAGR of 5.0% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-07-31
Pages: 158
The global OPO-containing Infant Formulas market size was US$ 1069 million in 2024 and is forecast to a readjusted size of US$ 1497 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 96
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1069 million in 2024 and is forecast to a readjusted size of US$ 1497 million by 2031 with a CAGR of 5.0% during the forecast period 2025-2031.
Published: 2025-03-13
Pages: 118
The global market for OPO-containing Infant Formulas was valued at US$ 1069 million in the year 2024 and is projected to reach a revised size of US$ 1497 million by 2031, growing at a CAGR of 5.0% during the forecast period.
Published: 2025-03-13
Pages: 93
The global market for OPO-containing Infant Formulas was estimated to be worth US$ 1020 million in 2023 and is forecast to a readjusted size of US$ 1433 million by 2030 with a CAGR of 5.0% during the forecast period 2024-2030.
Published: 2025-01-01
Pages: 112
Valued at US$ 1069 million in 2024, the global OPO-containing Infant Formulas market is forecast to reach US$ 1433 million by 2030, at a CAGR of 5.0% during the forecast period.
Published: 2025-01-01
Pages: 165
The global market for OPO-containing Infant Formulas was valued at US$ 1020 million in the year 2023 and is projected to reach a revised size of US$ 1433 million by 2030, growing at a CAGR of 5.0% during the forecast period.
Published: 2025-01-01
Pages: 89
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now